|
1P Sitravatinib + tislelizumab in patients with anti-PD-(L)1 refractory/resistant metastatic non-small cell lung cancer (NSCLC) |
|
|
|
Titel: |
1P Sitravatinib + tislelizumab in patients with anti-PD-(L)1 refractory/resistant metastatic non-small cell lung cancer (NSCLC) |
Auteur: |
Gao, B. Ma, Z. Yu, X. Huang, D. Zhao, J. Day, D. Body, A.L. Zhou, Q. Chu, Q. Pan, H. Cui, J. Li, H. Sun, J. Zhang, J. Fei, C. Wu, Y-L. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 33 () nr. S1 pagina's S1 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|